Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Use of Proton Pump Inhibitors Increases Risk of Upper Respiratory Tract Infections in Children: A Birth Cohort Study.

Pediatric pulmonology·2026
Same author

Type 2 diabetes morbidity, mortality and its associated risk factors across Brazilian regions: findings from the Global Burden of Disease Study 2021.

Archives of endocrinology and metabolism·2026
Same author

[Sociodemographic and environmental factors in infants under one year of age hospitalized for acute bronchiolitis: case-control study].

Andes pediatrica : revista Chilena de pediatria·2026
Same author

The usefulness of the new SOBIstat-F<sup>®</sup> device in children with severe acute asthma attacks in the emergency department: a randomized clinical trial.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Corticosteroids in acute asthma care in children: what, why, and when.

Expert opinion on pharmacotherapy·2026
Same author

Telemedicine Gatekeeping Over 15,000 Patients from Specialist Consultation Waiting Lists: A Cost-Minimization Study.

Telemedicine reports·2025

Related Experiment Video

Updated: Jun 6, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

Post infectious bronchiolitis obliterans in children.

Gilberto B Fischer1, Edgar E Sarria, Rita Mattiello

  • 1Department of Paediatrics, Universidade Federal de Ciencias da Saude, Porto Alegre, Brazil. gbuenof@terra.com.br

Paediatric Respiratory Reviews
|November 27, 2010
PubMed
Summary

Bronchiolitis Obliterans (BO) is a rare obstructive lung disease. This review focuses on the post-infectious type in children, its epidemiology, diagnosis, and treatment.

More Related Videos

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
06:15

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation

Published on: November 10, 2023

Related Experiment Videos

Last Updated: Jun 6, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
06:15

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation

Published on: November 10, 2023

Area of Science:

  • Pulmonology
  • Pediatric Respiratory Medicine

Background:

  • Bronchiolitis Obliterans (BO) is a rare, chronic obstructive lung disease affecting the small airways.
  • In children, it commonly presents as post-infectious BO following severe viral infections.
  • Post-transplant BO is increasing due to organ and bone-marrow transplants.

Purpose of the Study:

  • To review current evidence on post-infectious Bronchiolitis Obliterans in children.
  • To discuss epidemiology, diagnosis, treatment, and prognosis.
  • To highlight areas of controversy for future research.

Main Methods:

  • Literature review of up-to-date evidence.
  • Synthesis of information on epidemiology, diagnosis, treatment, and prognosis.
  • Identification of controversial aspects and future research directions.

Main Results:

  • Post-infectious BO in children is linked to early-life viral infections.
  • Post-transplant BO is progressive, unlike the generally non-progressive post-infectious form.
  • Both forms share pathological pathways leading to bronchiolar obliteration.

Conclusions:

  • Post-infectious Bronchiolitis Obliterans requires further investigation regarding its long-term course and management.
  • Understanding shared pathways may offer therapeutic insights.
  • Further research is needed to address current controversies and improve patient outcomes.